FluGen, Inc. is a privately held biotechnology company developing novel influenza vaccine technology. The REDEE FLU vaccine contains mutations in the M2 gene of the virus, allowing it to induce immune responses without shedding infectious virus particles.
Market
Influenza vaccine development
Location
Madison,
Wisconsin,
USA
Coinvestors
State of Wisconsin Investment Board, Venture Investors, Wisconsin Alumni Research Foundation